Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
US Stock MarketDetailed Quotes
InMed Pharmaceuticals (INM)
- 0.6245
- -0.0305-4.66%
Close May 13 16:00 ET
2.07MMarket Cap-0.29P/E (TTM)
0.6647High0.6340Low7.76KVolume0.6613Open0.6550Prev Close5.06KTurnover0.36%Turnover RatioLossP/E (Static)3.31MShares7.980052wk High0.30P/B1.35MFloat Cap0.575052wk Low--Dividend TTM2.16MShs Float3210.0000Historical High--Div Yield TTM4.69%Range %0.5750Historical Low0.6520Avg Price1Lot Size
InMed Pharmaceuticals (INM) Key Financial Indicators
INM Earnings per Share (EPS)
According to the latest financial report of InMed Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.73. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
INM Free Cash Flow (FCF)
Interested in knowing about InMed Pharmaceuticals's free cash flow? The latest report shows it as -1.70M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
INM Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of InMed Pharmaceuticals shows that the company's current ratio is 3.11, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
INM Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of InMed Pharmaceuticals, the quick ratio is 2.33, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
INM Return on Equity (ROE)
Want to learn more about the financial health of InMed Pharmaceuticals? The latest ROE figure is -36.00%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
INM Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of InMed Pharmaceuticals, the total asset return on investment (ROA) is -29.19%.
Currency: USD
Quarterly
Loading...
INM Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check InMed Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 22.46%.
Currency: USD
Quarterly
Loading...
INM Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of InMed Pharmaceuticals, the net profit margin is -247.29%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm